About
VYNE Therapeutics is a clinical-stage biopharmaceutical company developing therapies targeting difficult therapeutic challenges primarily through its InhiBET™ BET inhibitor platform.
Explore VYNE Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.